On the 19th January, Joop van Griensven, the president of Pain Alliance Europe, has participated at the headquarters of HOPE – European Hospital and Healthcare Federation, to an event introducing ICT4Life.
ICT4Life is a project funded by the European Union’s Horizon 2020 Research and Innovation Programme, which brings together actors in the domain of research, innovation and IT development, together with non-profit organisations representing the elderly generation and hospital associations but also universities.
The project aims to provide new services for integrated care employing user-friendly ICT tools, in order to help patients with Parkinson’s, Alzheimer’s and other dementias and their caregivers’ quality of life and autonomy at home.
Joop van Griensven shares some after-event thoughts: “Such projects, although not specifically aimed to serve chronic pain patients, do have their undoubted value for this category, knowing that unfortunately chonic pain is related to almost all chronical diseases. Technical developments, adjustments to specific targets groups, including chronic pain, and this whole concept of integrated care in which partners with different level of inputs are working together to improve the delivery of health and social services, would definitely benefit the patients we represent.”
Under the agenda of the “ICT4Life approach and contribution to the challenges of integrated care” event, there there have been presentation and discussions about the approach of the organisations involved in the project on integrated care and chronic diseases, but also the technical approach, with a demo of the technologies developed during the first year of the project.
A video introduction of the ICT4Life laboratories, the perspective of patients, care-givers and professionals and how do ICT4Life technologies improve the condition of end-users? – were among the topics of this event.
If you would like to find out more about the next steps of the project ICT4Life , visit ICT4Life website and follow the project updates on Facebook, LinkedIn and Twitter.